Spark Biomedical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Spark Biomedical General Information

Description

Developer of wearable neurostimulation devices designed to offer opioid withdrawal relief. The company's devices use transcutaneous auricular neurostimulation to stimulate nerves on and around the ear to overcome withdrawal, heal from addiction, and achieve a better quality of life, enabling patients to use a non-pharmaceutical approach and receive long-term recovery support.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 18208 Preston Road
  • Suite, D9 531
  • Dallas, TX 75252
  • United States
+1 (844)
Primary Industry
Therapeutic Devices
Corporate Office
  • 18208 Preston Road
  • Suite, D9 531
  • Dallas, TX 75252
  • United States
+1 (844)

Spark Biomedical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spark Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 02-Mar-2026 Completed Generating Revenue
10. Later Stage VC (Series A) 30-Apr-2025 Completed Generating Revenue
9. Grant 29-Aug-2023 Completed Generating Revenue
8. Later Stage VC (Series A) 12-May-2023 Completed Generating Revenue
7. Seed Round 01-Jan-2022 Completed Generating Revenue
6. Grant 16-Nov-2021 Completed Generating Revenue
5. Grant 01-Aug-2021 Completed Generating Revenue
4. Grant 05-Feb-2021 Completed Generating Revenue
3. Grant 31-Aug-2020 $218K Completed Generating Revenue
2. Grant 30-Sep-2019 $1.25M Completed Generating Revenue
To view Spark Biomedical’s complete valuation and funding history, request access »

Spark Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A-3 1,099,019 $0.000100 $0.58 $0.58 1x $0.58 3.88%
Seed 3,886,740 $0.000100 $0.9 $0.9 1x $0.9 13.73%
To view Spark Biomedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Spark Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of wearable neurostimulation devices designed to offer opioid withdrawal relief. The company's devices use tra
Therapeutic Devices
Dallas, TX
30 As of 2026

San Diego, CA
 

Bloomington, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spark Biomedical Competitors (23)

One of Spark Biomedical’s 23 competitors is Mainstay Medical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mainstay Medical Venture Capital-Backed San Diego, CA
Saluda Medical Formerly PE-Backed Bloomington, MN
Iovera Formerly VC-backed Brisbane, CA
BrainQ Venture Capital-Backed Jerusalem, Israel
Neuros Medical Venture Capital-Backed Aliso Viejo, CA
You’re viewing 5 of 23 competitors. Get the full list »

Spark Biomedical Patents

Spark Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12747426-B1 Ex-vivo enhancement of platelet function during blood processing Active 29-Oct-2025
US-12752102-B1 Disposable electrodes for portable stimulation devices and systems and methods for replacement of the disposable electrodes Active 17-Jun-2025
US-12465764-B1 Delivery of non-penetrating electrical neurostimulation therapy Active 30-Sep-2024
US-20260131142-A1 Improved delivery of non-penetrating electrical neurostimulation therapy Pending 30-Sep-2024
WO-2026072777-A1 Improved delivery of non-penetrating electrical neurostimulation therapy Pending 30-Sep-2024 A61N1/36021
To view Spark Biomedical’s complete patent history, request access »

Spark Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spark Biomedical Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
HIS Kingdom Resources Fund Venture Capital Minority
Northwell Holdings Corporate Venture Capital Minority
Pathway to Cures Not-For-Profit Venture Capital Minority
United States Department of War Government
Southwest National Pediatric Device Innovation Consortium Accelerator/Incubator Minority
You’re viewing 5 of 14 investors. Get the full list »

Spark Biomedical FAQs

  • When was Spark Biomedical founded?

    Spark Biomedical was founded in 2018.

  • Where is Spark Biomedical headquartered?

    Spark Biomedical is headquartered in Dallas, TX.

  • What is the size of Spark Biomedical?

    Spark Biomedical has 30 total employees.

  • What industry is Spark Biomedical in?

    Spark Biomedical’s primary industry is Therapeutic Devices.

  • Is Spark Biomedical a private or public company?

    Spark Biomedical is a Private company.

  • What is Spark Biomedical’s current revenue?

    The current revenue for Spark Biomedical is .

  • How much funding has Spark Biomedical raised over time?

    Spark Biomedical has raised $34.6M.

  • Who are Spark Biomedical’s investors?

    HIS Kingdom Resources Fund, Northwell Holdings, Pathway to Cures, United States Department of War, and Southwest National Pediatric Device Innovation Consortium are 5 of 14 investors who have invested in Spark Biomedical.

  • Who are Spark Biomedical’s competitors?

    Mainstay Medical, Saluda Medical, Iovera, BrainQ, and Neuros Medical are some of the 23 competitors of Spark Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process